AT & S Austria Technologie & Systemtechnik Aktiengesellschaft (ATS)
Vienna Exchange · Austria · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 140.40 |
|---|---|
| 52-week range | 25.00 – 242.00 |
| Return, 1 month / 3 months | −32.0% / −20.9% |
| Return, 1 year / 3 years | +381.6% / +494.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 32 |
| Volatility (1 year) | 87.6% |
| Worst drawdown (1 year) | -50.1% |
| Average daily value traded | 22.24M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
AT&S Austria Technologie & Systemtechnik Aktiengesellschaft, usually called AT&S, is a manufacturer of printed circuit boards and integrated circuit substrates. The company supplies these components to makers of smartphones, computers, automotive electronics, medical devices and industrial equipment. It also provides related services such as design support and assembly solutions for electronics producers. AT&S is based in Leoben, Austria, and serves customers in Europe, Asia and North America through production sites in several countries.
AT & S Austria Technologie & Systemtechnik Aktiengesellschaft trades under the code ATS on the Vienna Exchange in Austria, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
AT & S Austria Technologie & Systemtechnik Aktiengesellschaft (ATS) trades on the Vienna Exchange in Austria. It last closed at EUR 140.40 on 22 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 38 of 84 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 381.6% and over the last three months it fell 20.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Vienna Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 14.5% | ||
| From 52-week high | -41.3% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -20.9% | ||
| 6-month return | 59.2% | ||
| 12-month return, skipping the last month | 608.4% | ||
| Stability (higher is calmer) | 7 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 87.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -50.1% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 22.24M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −20.7% |
|---|---|
| 1 month | −32.0% |
| 3 months | −20.9% |
| 6 months | +59.2% |
| 1 year | +381.6% |
| 3 years | +494.4% |
| 5 years | +325.6% |
Signals
| 50-day / 200-day average | 176.25 / 122.61 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 14.93 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Jul 2023 | EUR 0.4000 |
| 26 Jul 2022 | EUR 0.9000 |
| 27 Jul 2021 | EUR 0.3900 |
| 28 Jul 2020 | EUR 0.2500 |
| 23 Jul 2019 | EUR 0.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Vienna Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.